Top Stories

Medtronic Upgraded To Outperform From Market Perform At William Blair

Analyst Ben Andrew of William Blair upgraded Medtronic, Inc. (MDT) from Market Perform to Outperform in a research report released on today.

Maxim Reiterates Buy Rating And Raises Achillion Price Target To $22

In a research note issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating and boosted his price target on Achillion Pharmaceuticals (ACHN) to …

H.C. Wainwright Initiates Coverage On EDAP At Buy, Announces $6 PT

In a research note issued this morning, H.C.

Roth Capital Initiates Research Coverage On Fusion IO Inc. With A Buy Rating

Roth Capital initiated coverage on Fusion IO Inc. (FIO) with a Buy rating and $12.

Intel Corporation Upgraded to Buy From Neutral At Roth Capital

Analyst Krishna Shankar of Roth Capital upgraded Intel Corporation (INTC) from Neutral to Buy, and boosted his price target on INTC from $28.00 to $35.

UPDATE: Roth Capital Resumes Coverage On Conatus Pharmaceuticals

In a report published today, Roth Capital analyst Ed Arce resumed coverage on Conatus Pharmaceuticals Inc. (CNAT) with a Buy rating and $19.

We Like Ariad’s Story But See Limited Newsflow, Says UBS’ Andrew Peters

Ariad Pharmaceuticals (ARIA) had its price target reduced by UBS from $7.50 to $7.

Canaccord Raises Price Target On Medifast; Expects Improved Profitability

In a research note released today, Canaccord analyst Scott Van Winkle maintained his Hold position on Medifast (MED) and upgraded his price target to $32.00 from $31.

OraSure Technologies Price Target Raised at Canaccord Following Agreement With AbbVie

In a research note issued today, Canaccord analyst Mark Massaro reiterated a Buy rating and boosted his price target on OraSure Technologies (OSUR) to $11.00 …

Canaccord Downgrades B/E Aerospace to Hold As Company Sale Looks Incrementally Less Likely

In a research report issued today, B/E Aerospace Inc. (BEAV) was downgraded by analyst Kenneth Herbert at Canaccord from a “buy” rating to a “hold” rating.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts